Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism
Authors:
Top Cited Papers
- 15 April 2024
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 76 (3) , e12954
Abstract
Osteoporosis (OP) is a severe global health issue that has significant implications for productivity and human lifespan. Gut microbiota dysbiosis has been demonstrated to be closely associated with OP progression. Melatonin (MLT) is an important endogenous hormone that modulates bone metabolism, maintains bone homeostasis, and improves OP progression. Multiple studies indicated that MLT participates in the regulation of intestinal microbiota and gut barrier function. However, the promising effects of gut microbiota‐derived MLT in OP remain unclear. Here, we found that OP resulted in intestinal tryptophan disorder and decreased the production of gut microbiota‐derived MLT, while administration with MLT could mitigate OP‐related clinical symptoms and reverse gut microbiota dysbiosis, including the diversity of intestinal microbiota, the relative abundance of many probiotics such as Allobaculum and Parasutterella, and metabolic function of intestinal flora such as amino acid metabolism, nucleotide metabolism, and energy metabolism. Notably, MLT significantly increased the production of short‐chain fatty acids and decreased trimethylamine N‐oxide‐related metabolites. Importantly, MLT could modulate the dynamic balance of M1/M2 macrophages, reduce the serum levels of pro‐inflammatory cytokines, and restore gut‐barrier function. Taken together, our results highlighted the important roles of gut microbially derived MLT in OP progression via the “gut‐bone” axis associated with SCFA metabolism, which may provide novel insight into the development of MLT as a promising drug for treating OP.Keywords
This publication has 102 references indexed in Scilit:
- The miR-224-5p/SIRT3/AMPK/mTOR axis is involved in the melatonin-mediated inhibition of glucocorticoid-induced osteoporosis by activating autophagyHuman Cell, 2023
- Tuna Bone Powder Alleviates Glucocorticoid‐Induced Osteoporosis via Coregulation of the NF‐κB and Wnt/β‐Catenin Signaling Pathways and Modulation of Gut Microbiota Composition and MetabolismMolecular Nutrition & Food Research, 2020
- Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced OsteoporosisJournal of Bone and Mineral Research, 2019
- Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolitesApplied Microbiology and Biotechnology, 2019
- Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potentialJournal of Cellular Physiology, 2019
- Estrogen Deficiency–Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic MiceJournal of Bone and Mineral Research, 2017
- Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley ratsCurrent Medical Science, 2017
- Gut Microbiome and Bone: to Build, Destroy, or Both?Current Osteoporosis Reports, 2017
- Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cellsJournal of Cellular Physiology, 2003
- Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosisThe American Journal of Medicine, 1993